Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor, is the first and only FDA-approved treatment for pain caused by diabetic peripheral
neuropathy. ... On Aug. 3, the agency approved
Cymbalta as a treatment for major depression in adults.
read more >>